Medicare Enrolled
Dr. Shilpa Oberoi, MD
Medical Oncology · Ocala, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Oberoi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Oberoi? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Oberoi
Dr. Shilpa Oberoi is a medical oncology in Ocala, FL, with 17 years in practice. Based on federal Medicare data, Dr. Oberoi performed 234,584 Medicare services across 5,243 unique beneficiaries.
Between the years covered by Open Payments, Dr. Oberoi received a total of $14,737 from 93 pharmaceutical and/or device companies across 806 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Oberoi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice▲ Top 10% volume in FL$ $14,737 industry payments
Medicare Practice Summary
Medicare Utilization ↗234,584
Medicare services
Top 10% in FL for medical oncology
5,243
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~13,799 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 87,720 | $0 | $4 |
| Azacitidine chemotherapy injection | 48,025 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 14,040 | $18 | $51 |
| Pembrolizumab injection (Keytruda) | 12,800 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 12,350 | $1 | $5 |
| Iron sucrose injection (Venofer) | 8,300 | $0 | $5 |
| Immune globulin infusion (Gammagard) | 8,192 | $36 | $108 |
| Paclitaxel chemotherapy injection | 7,950 | $0 | $2 |
| Iron infusion (Monoferric) | 6,700 | $16 | $57 |
| Epoetin alfa injection (Procrit) for anemia | 6,140 | $6 | $23 |
| Injection, eflapegrastim-xnst, 0.1 mg | 4,752 | $26 | $116 |
| Blood draw (venipuncture) | 2,731 | $8 | $9 |
| Complete blood count (CBC) with differential | 2,565 | $8 | $29 |
| Dexamethasone injection (steroid) | 2,429 | $0 | $3 |
| Office visit, established patient (20-29 min) | 1,404 | $65 | $239 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,140 | $1 | $28 |
| Drug injection, under skin or into muscle | 1,004 | $10 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 724 | $0 | $9 |
| Injection of additional new drug or substance into vein | 657 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 550 | $97 | $378 |
| Office visit, established patient (30-39 min) | 494 | $94 | $339 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 414 | $1 | $6 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 400 | $47 | $189 |
| Injection, zoledronic acid, 1 mg | 265 | $6 | $69 |
| Injection, carboplatin, 50 mg | 262 | $2 | $41 |
| Injection, diphenhydramine hcl, up to 50 mg | 237 | $1 | $3 |
| New patient office visit (45-59 min) | 227 | $122 | $453 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 212 | $16 | $56 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 189 | $54 | $206 |
| Administration of chemotherapy into vein, each additional hour | 183 | $21 | $79 |
| Injection of drug or substance into vein | 179 | $27 | $156 |
| Injection, magnesium sulfate, per 500 mg | 133 | $1 | $2 |
| Administration of additional new drug or substance into vein, 1 hour or less | 113 | $49 | $178 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 104 | $22 | $84 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 102 | $17 | $59 |
| Infusion, normal saline solution , 1000 cc | 91 | $2 | $7 |
| Infusion into a vein for hydration, each additional hour | 88 | $10 | $42 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 68 | $1 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 65 | $24 | $156 |
| Initial hospital admission, high complexity | 64 | $132 | $556 |
| Hospital follow-up visit, low complexity | 64 | $38 | $109 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 62 | $3 | $11 |
| Administration of additional new drug or substance into vein using push technique | 60 | $42 | $170 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 57 | $25 | $89 |
| Office visit, established patient (10-19 min) | 57 | $41 | $147 |
| Hospital follow-up visit, moderate complexity | 40 | $62 | $197 |
| Red blood count automated, with additional calculations | 38 | $5 | $20 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 37 | $132 | $467 |
| Drawing of blood for a medical problem | 37 | $63 | $277 |
| Initial hospital admission, moderate complexity | 28 | $103 | $377 |
| Automated urinalysis | 27 | $2 | $8 |
| Office visit, established patient, complex (40-54 min) | 14 | $134 | $474 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
44.2% high complexity
52.4% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,737
Total received (2018-2024)
Avg $2,105/year across 7 years
Top 36% in FL for medical oncology
93
Companies
806
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,690 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$46 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,516
2023$2,617
2022$2,525
2021$2,005
2020$1,625
2019$1,823
2018$1,626
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,452
Janssen Biotech, Inc.
$1,032
PFIZER INC.
$788
E.R. Squibb & Sons, L.L.C.
$788
Amgen Inc.
$679
Celgene Corporation
$534
GENZYME CORPORATION
$521
Astellas Pharma US Inc
$390
Merck Sharp & Dohme LLC
$381
Genentech USA, Inc.
$376
Seagen Inc.
$350
GlaxoSmithKline, LLC.
$330
Incyte Corporation
$320
Merck Sharp & Dohme Corporation
$307
AstraZeneca Pharmaceuticals LP
$305
Bayer Healthcare Pharmaceuticals Inc.
$289
Lilly USA, LLC
$286
Eisai Inc.
$276
Octapharma USA, Inc.
$258
Gilead Sciences, Inc.
$232
Epizyme, Inc.,
$214
GE HEALTHCARE
$205
Bayer HealthCare Pharmaceuticals Inc.
$194
Takeda Pharmaceuticals U.S.A., Inc.
$192
Daiichi Sankyo Inc.
$191
JAZZ PHARMACEUTICALS INC.
$177
Puma Biotechnology, Inc.
$163
Regeneron Healthcare Solutions, Inc.
$159
Foundation Medicine, Inc.
$157
Rigel Pharmaceuticals, Inc.
$153
EMD Serono, Inc.
$152
Seattle Genetics, Inc.
$149
ABBVIE INC.
$137
Kite Pharma, Inc.
$129
Karyopharm Therapeutics Inc.
$107
MorphoSys, US Inc.
$104
ARRAY BIOPHARMA INC
$100
Mirati Therapeutics, Inc.
$91
Pharmacyclics LLC, An AbbVie Company
$90
Alexion Pharmaceuticals, Inc.
$90
Pharmacosmos Therapeutics Inc.
$88
EISAI INC.
$88
BeiGene USA, Inc.
$83
TESARO, Inc.
$82
Myriad Genetic Laboratories, Inc.
$71
Agios Pharmaceuticals, Inc.
$65
Global Blood Therapeutics, Inc.
$63
TAIHO ONCOLOGY, INC.
$59
Ipsen Biopharmaceuticals, Inc
$58
Stemline Therapeutics Inc.
$54
SERVIER PHARMACEUTICALS LLC
$54
Taiho Oncology, Inc.
$54
AVEO Pharmaceuticals, Inc.
$51
PharmaEssentia USA Corporation
$49
TerSera Therapeutics LLC
$48
Clovis Oncology, Inc.
$48
Tempus AI, Inc
$44
PUMA BIOTECHNOLOGY, INC.
$43
Pharmacyclics LLC, an AbbVie Company
$40
Deciphera Pharmaceuticals Inc.
$39
G1 Therapeutics, Inc.
$38
AMAG Pharmaceuticals, Inc.
$35
Shire North American Group Inc
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$33
Heron Therapeutics, Inc.
$32
AbbVie Inc.
$29
CTI BioPharma Corp.
$29
SANOFI-AVENTIS U.S. LLC
$29
Sirtex Medical Inc
$28
Spectrum Pharmaceuticals Inc.
$25
Blueprint Medicines Corporation
$25
Teva Pharmaceuticals USA, Inc.
$25
Adaptive Biotechnologies Corporation
$24
ADC Therapeutics America, Inc.
$23
ImmunoGen, Inc.
$22
Kyowa Kirin, Inc.
$21
Array BioPharma Inc.
$19
Sun Pharmaceutical Industries Inc.
$19
Helsinn Therapeutics (U.S.), Inc.
$19
Exelixis Inc.
$17
Advanced Accelerator Applications
$17
Emmaus Medical, Inc.
$16
Legend Biotech USA Inc.
$16
Alnylam Pharmaceuticals Inc.
$16
Lexicon Pharmaceuticals, Inc.
$15
Sobi, Inc
$15
Dova Pharmaceuticals
$15
Dendreon Pharmaceuticals LLC
$14
Servier Pharmaceuticals LLC
$13
Tactile Systems Technology Inc
$13
Verastem, Inc.
$12
EUSA Pharma (US) LLC
$12
Acrotech Biopharma LLC
$12
Top 3 companies account for 22.2% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALOXI · ALUNBRIG · AYVAKIT · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CALQUENCE · CARVYKTI · CERDELGA · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Elahere · Endari · Enhertu · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Flexitouch Plus · Folotyn · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · HYQVIA · Halaven · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO (sonidegib) capsules · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $6 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
6
Per 100K population
1.5
County median income
$58,535
Nearest hospital
ADVENTHEALTH OCALA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Oberoi is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Oberoi experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Oberoi performed 87,720 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Oberoi receive payments from pharmaceutical companies?
Yes. Dr. Oberoi received a total of $14,737 from 93 companies across 806 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Oberoi's costs compare to other medical oncologys in Ocala?
Dr. Oberoi's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Oberoi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Ocala
Browse medical oncologys in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology